摘要
目的探讨肝动脉化疗栓塞(TACE)对肝细胞癌(HCC)患者甲胎蛋白异质体(AFPL3)的影响。方法用酶联免疫法测定HCC患者术前、术后1周血清AFP、AFP-L3%(AFP-L3/AFP百分比)的数值。结果术后1周AFP-L3%的值与术前比较,差异有统计学意义(P<0.001)。结论 HCC患者接受TACE治疗后,AFP-L3%的数值明显降低,AFP-L3%可能成为HCC患者治疗的评估指标。
Objective To investigate the influence of the AFP-L3 in treatment of hepatocellular carcinoma(HCC) patients with transcatheter arterial chemoembolization(TACE).Methods Determination of the serum AFP,AFP-L3% of HCC patients before or after one weeks,by enzyme linked immunosorbent assay.Results One weeks after the operation,the value of AFP-L3% compared with those before operation,the difference was significantly(P 0.001).Conclusions In treatment of hepatocellular carcinoma(HCC) patients with transcatheter arterial chemoembolization(TACE),the values of AFP-L3% of was decrease significantly;And the AFP-L3% of the HCC may be used as evaluation index for the treatment of patients.
出处
《中国肿瘤临床与康复》
2013年第8期814-815,共2页
Chinese Journal of Clinical Oncology and Rehabilitation